| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.69M | - | |
| Other | 52.8K | $8.53M | - | |
| Other | 46.8K | $7.56M | - | |
| Other | 39.6K | $6.41M | -36,937 | |
| Other | 36.8K | $5.96M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | Roberts Eiry49 | Chief Medical Officer | Sell | 1,457 | $140.79 | $205,131.90 | -6.5% | -1.6% | +9.7% | |
| Jan 31, 2024 | Onyia Jude54 | Chief Scientific Officer | Sell | 126 | $141.94 | $17,884.44 | -1.1% | -1.6% | +9.7% | |
| Jan 31, 2024 | Lippoldt Darin60 | Chief Legal Officer | Sell | 1,250 | $140.65 | $175,809.75 | -3.3% | -1.6% | +9.7% | |
| Jan 31, 2024 | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 2,707 | $140.69 | $380,844.58 | -0.5% | -1.6% | +9.7% | |
| Jan 31, 2024 | Gano Kyle54 | Chief Business Development Off | Sell | 1,541 | $140.70 | $216,812.54 | -1.2% | -1.6% | +9.7% | |
| Jan 31, 2024 | Benevich Eric62 | Chief Commercial Officer | Sell | 1,207 | $140.78 | $169,926.77 | -3.1% | -1.6% | +9.7% | |
| Jan 31, 2024 | Abernethy Matt57 | Chief Financial Officer | Sell | 1,283 | $140.72 | $180,538.76 | -4.3% | -1.6% | +9.7% | |
| Jan 22, 2024 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 10,000 | $139.86 | $1,398,553.00 | -21.8% | -4.4% | +4.3% | |
| Jan 9, 2024 | Gorman Kevin Charles55 | Chief Executive Officer | Sale+OE | 167,858 | $133.02 | $22,328,417.31 | -14.4% | +4.3% | +3.7% | |
| Jan 2, 2024 | Gano Kyle54 | Chief Business Development Off | Sale+OE | 75,000 | $131.47 | $9,860,194.47 | -22.4% | +7.3% | +4.7% |